Mana Capital (MAAQ) to Combine with Cardio Diagnostics in $75M Deal

Mana Capital (NASDAQ:MAAQ) has entered into a definitive agreement to combine with biopharmaceutical firm Cardio Diagnostics at an enterprise value of $75 million. Chicago-based Cardio sells heart health tests direct to consumers via its website and purports to be able to detect whether a patient may experience a heart attack in the near future. The
Read More